Search Results 301-310 of 17152 for monoclonal antibody

  1. Anifrolumab-fnia (intravenous route) - Side effects & uses - Mayo Clinic

    It is a monoclonal antibody that changes the immune system to help control lupus symptoms. This medicine is available only with your doctor's prescription ...

  2. Trastuzumab-pkrb (intravenous route) - Side effects & uses - Mayo Clinic

    Trastuzumab-pkrb is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of ...

  3. Asher A. Chanan-Khan, M.D. - Mayo Clinic Faculty Profiles

    Monoclonal antibody therapies in multiple myeloma. Preclinical models of Waldenstrom macroglobulinemia. Significance to Patient Care. Dr. Chanan-Khan is ...

  4. Crohn's disease - Diagnosis and treatment - Mayo Clinic

    Risankizumab also is a monoclonal antibody. This medicine acts against a molecule known as interleukin-23. Risankizumab was recently approved for treating ...

  5. Mayo Clinic Q & A - Dr. Gregory Poland - COVID-19 Update - ...

    In other words, people getting an injection of monoclonal antibodies and being protected for the next 90 plus days. Dr. Halena Gazelka 19:52. How interesting.

  6. Trastuzumab-strf (intravenous route) - Side effects & uses - Mayo Clinic

    Trastuzumab-strf is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of ...

  7. Signs Midwest COVID-19 surge may be leveling off as Mayo Clinic prepares for first round of vaccinations

    As are the outpatient therapies, such as the monoclonal antibody treatments, Mayo Clinic is offering to help keep patients out of the hospitals. "We still ...

  8. Autoimmune encephalitis: Paving the way to better outcomes - Mayo Clinic

    Mayo Clinic is exploring the potential benefit of inebilizumab, a monoclonal antibody recently approved for the treatment of neuromyelitis optica spectrum ...

  9. Research highlights in Neurology and Neurosurgery ― September 2019 - Mayo Clinic

    Staining with a monoclonal antibody was performed. All study participants had sufficient submandibular gland tissue on at least one side; 12 of the 14 ...

  10. Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients with Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom Macroglobulinemia, or Mantle Cell Lymphoma - Mayo Clinic

    RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread ...